• CVS Health swung to third-quarter GAAP diluted earnings of $1.68 per share, reflecting the absence of a prior-year goodwill impairment charge.
• Total revenues rose 5% year-over-year to $108.4 billion, primarily driven by growth in Health Services and Health Care Benefits.
• Nine-month cash flow from operations more than doubled year-over-year to $15.32 billion.
• More than 69% of Aetna Medicare Advantage members are in 2027 plans rated at least four stars.
• Full-year 2026 guidance increased to at least $6.98 in GAAP diluted EPS and at least $15.5 billion in cash flow from operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611040630PR_NEWS_USPR_____NE87938) on November 04, 2026, and is solely responsible for the information contained therein.